Clinical Trial Radar

beta

Advanced

Trial Radar AI Trial Candidate or Patient Patient Caregiver Healthcare Pro Biotech Pro Biotech Investor Researcher Other
	Let's discuss and explore clinical trials with AstraZeneca as a lead sponsor or collaborator. Showing clinical trials for Diabetes. I can help you find nearby clinical trials and understand health conditions and treatments.

Search by keywords...

Search by location, facility...

Study Title	Status
Renal Mechanism of Action/Splay vs. TmG (MOA) NCT00726505	Terminated
The Belgian Diabetes in Pregnancy Study: BEDIP-N Study NCT02036619	Completed
Chinese Multiple Dose Escalation (MDE) High Dose Study (COTA China PK) NCT05437848	Completed
Indian Phenotype Registry (IP Registry) NCT03363594	Completed
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus NCT02229383	CompletedResults Posted
Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus NCT00108004	Completed
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin NCT00701935	TerminatedResults Posted
An Observational, Cross Sectional Study to Assess the Prevalence of Chronic Kidney Disease (CKD) in Type 2 Diabetes Patients (START-INDIA) NCT02208921	Completed
ENhancing Outcomes Through Goal Assessment and Generating Engagement in Diabetes Mellitus (ENGAGE-DM) NCT02910089	CompletedResults Posted
OPtimal Type 2 dIabetes Management Including Benchmarking and Standard trEatment. (Optimise) NCT00681850	Completed
The Effect of Injectable Therapies on Quality of Life in Diabetes NCT03222245	Completed
Prospective Diabetes Registry of Patients With Type 2 Diabetes Mellitus on SGLT 2 Inhibitor Therapy in Singapore NCT02578563	Completed
Quality of Life and Treatment Satisfaction of People With Type 2 Diabetes: A European Survey (PANORAMA) NCT00916513	Completed
Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes NCT00064714	Completed
Investigate the Effect of AZD1656 on the Pharmacokinetics of Sitagliptin in Patients With Type 2 Diabetes Mellitus NCT01095991	Completed
Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus NCT01082120	Completed
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo NCT02229396	CompletedResults Posted
Management of Diabetes Mellitus Patients With Retinopathy NCT00828425	Completed
A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With Type 2 Diabetes Mellitus (IRAK4) NCT07433062	Recruiting
Impact of Diabetes on Left Ventricular Remodeling (P3) NCT01052272	CompletedResults Posted
Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in Taiwan NCT03084965	Completed
Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus. (SOLSTICE) NCT06579105	Completed
Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus NCT02500979	CompletedResults Posted
A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone NCT02419612	CompletedResults Posted
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus (T2DM) Aged 10 to Below 18 Years Old NCT03199053	CompletedResults Posted
Evaluation of the Effect of Pramlintide on Satiety and Food Intake NCT00042601	Completed
A Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With Type 2 Diabetes Mellitus NCT02749435	Terminated
To Assess Safety of Fixed Dose Combination of Dapagliflozin and Saxagliptin in Type 2 Diabetes Mellitus Patients NCT04445714	CompletedResults Posted
Type 2 Diabetes Mellitus Patients' Characteristics and Management by General Practitioners and Endocrinologists NCT03209089	Completed
A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas NCT00313313	CompletedResults Posted
Study to Assess the Absorption, Distribution, Metabolism and Excretion of AZD1656 in Type 2 Diabetes Mellitus (T2DM) (ADME) NCT00960791	Completed
Japan Dose Regimen Study of AZD1656 in Japanese Type 2 Diabetes Mellitus Patients NCT01152385	CompletedResults Posted
Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise NCT00316082	CompletedResults Posted
An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes NCT00229658	CompletedResults Posted
Trial to Evaluate the Efficacy and Safety of Dapagliflozin in Japanese Type 2 Diabetes Mellitus Patients NCT00972244	CompletedResults Posted
A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise NCT00327015	CompletedResults Posted
Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients NCT01020123	CompletedResults Posted
Efficacy of 500µg Roflumilast Once Daily Versus Placebo Over 12 Weeks in Patients With Diabetes Mellitus Type 2. A Double Blind, Parallel Group, Proof of Concept Clinical Study (FORTUNA) NCT01140542	Completed
Phase III Insulin Add-On Asia Regional Program - ST NCT02096705	CompletedResults Posted
Multi-center, Single Arm, Observational Study to Evaluate the Safety of Dapagliflozin in Type 2 Diabetes Mellitus Patients in China (DONATE) NCT03156985	Completed
Real World Assessment of Clinical Outcome Changes -Including Month of Ramadan-for Dapagliflozin in Management of Type II Diabetes Mellitus (REWARD) NCT02805361	Completed
A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus NCT00313183	Completed
Characteristics of Patients With Type 2 Diabetes Mellitus Receiving Treatment With Dapagliflozin Versus Sitagliptin: An Analysis of Commercial Claims and Linked Laboratory Data NCT03078049	Completed
Economic Outcomes of EQW (Exenatide Once Weekly) vs. IG (Insulin Glargine) in T2D Patients Who Are New to Injectable Therapy NCT02843399	Completed
Effects of Dapagliflozin 10 mg on Insulin Resistance in Patients With Type 2 Diabetes Mellitus (DERISC) NCT02426541	CompletedResults Posted
Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus NCT01206647	Unknown status
A Phase I Study to Assess the Pharmacodynamics of Oral AR-C165395XX in Subjects With Type 2 Diabetes Mellitus (T2DM) NCT02367066	CompletedResults Posted
Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease (PLANET 1) NCT00296374	CompletedResults Posted
Effects of Rosuvastatin on the, in Vivo, Kinetic of apoB and apoA1, Using Stable Isotopes, in Type 2 Diabetic Patients NCT00658463	Completed
Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP) NCT06099067	Completed

Clinical Trial Radar

Phase

Type

Study Type

Age Group

Biological Sex

Placebo

Phase

Type

Study Type

Age Group

Biological Sex